These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11060707)

  • 1. Apoptosis modulators in the therapy of neurodegenerative diseases.
    Deigner HP; Haberkorn U; Kinscherf R
    Expert Opin Investig Drugs; 2000 Apr; 9(4):747-64. PubMed ID: 11060707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on pharmacological approaches to neurodegenerative diseases.
    Scatena R; Martorana GE; Bottoni P; Botta G; Pastore P; Giardina B
    Expert Opin Investig Drugs; 2007 Jan; 16(1):59-72. PubMed ID: 17155854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches.
    Camins A; Pallas M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2008; 30(1):43-65. PubMed ID: 18389097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
    Dailah HG
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.
    Saporito MS; Hudkins RL; Maroney AC
    Prog Med Chem; 2002; 40():23-62. PubMed ID: 12516522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracellular signaling pathways, apoptosis and neurodegenerative diseases].
    Marcilhac A
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):203-14. PubMed ID: 15689335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in neurodegenerative disorders.
    Mattson MP
    Nat Rev Mol Cell Biol; 2000 Nov; 1(2):120-9. PubMed ID: 11253364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcuminoids in neurodegenerative diseases.
    Kim DS; Kim JY; Han Y
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis.
    Verma DK; Gupta S; Biswas J; Joshi N; Singh A; Gupta P; Tiwari S; Sivarama Raju K; Chaturvedi S; Wahajuddin M; Singh S
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2078-2096. PubMed ID: 29551729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.